Sarepta Therapeutics (SRPT) Interest Coverage Ratio (QoQ) (2010 - 2026)
Sarepta Therapeutics (SRPT) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.63% |
| Dec 31, 2025 | 11,041.56% |
| Sep 30, 2025 | -192.00% |
| Jun 30, 2025 | 133.64% |
| Mar 31, 2025 | -103.63% |
| Dec 31, 2024 | 33,738.95% |
| Sep 30, 2024 | 117.06% |
| Jun 30, 2024 | -102.99% |
| Mar 31, 2024 | 864.85% |
| Dec 31, 2023 | 84.07% |
| Sep 30, 2023 | 84.41% |
| Jun 30, 2023 | -29.99% |
| Mar 31, 2023 | -1,839.63% |
| Dec 31, 2022 | 112.68% |
| Sep 30, 2022 | 28.39% |
| Jun 30, 2022 | -126.38% |
| Mar 31, 2022 | 41.99% |
| Dec 31, 2021 | -468.02% |
| Sep 30, 2021 | 83.88% |
| Jun 30, 2021 | -6.70% |